Climb Bio (CLYM) Exchange Rate Effect (2020 - 2025)
Climb Bio (CLYM) posted Exchange Rate Effect of $24000.0 for Q2 2025, up 200.0% on a QoQ basis from -$24000.0 in Q1 2025, and up 26.32% year-over-year from $19000.0 in Q2 2024.
Climb Bio (CLYM) Exchange Rate Effect (2020 - 2025) Analysis & Trends
Climb Bio's Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $24000.0 for Q2 2025.
- Quarterly Exchange Rate Effect rose 26.32% year-over-year to $24000.0 in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $24000.0 (down 47.83% YoY) and the FY2024 annual result came in at $42000.0, down 86.18% from the prior year.
- Exchange Rate Effect was $24000.0 for Q2 2025 at Climb Bio, up from -$24000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.8 million in Q4 2022 and bottomed at -$1.1 million in Q2 2022.
- A 5-year average of $10764.7 and a median of $19000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect sank 1355.7% — and 2024, when it surged 2600.0%.
- Climb Bio's Exchange Rate Effect stood at $79000.0 in 2021, then jumped by 2193.67% to $1.8 million in 2022, then tumbled by 118.21% to -$330000.0 in 2023, then soared by 82.73% to -$57000.0 in 2024, then surged by 142.11% to $24000.0 in 2025.
- Business Quant data shows CLYM's Exchange Rate Effect at $24000.0 in Q2 2025, -$24000.0 in Q1 2025, and -$57000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Dec 31, 2024 | -57,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Sep 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Dec 31, 2023 | -330,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 399,000.00 |
| Jun 30, 2023 | 399,000.00 |
| Mar 31, 2023 | 231,000.00 |
| Mar 31, 2023 | 231,000.00 |